Yao Yu-Cheng, Chou Po-Hsin, Lin Hsi-Hsien, Wang Shih-Tien, Chang Ming-Chau
Department of Orthopedics and Traumatology, Taipei Veterans General Hospital, Beitou District, Taipei, Taiwan.
Department of Surgery, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Global Spine J. 2023 Mar;13(2):472-478. doi: 10.1177/21925682211000323. Epub 2021 Mar 18.
Retrospective case-control study.
This study aims to present the clinical and radiographical outcomes of the titanium-polyetheretherketone (Ti/PEEK) composite cage compared to those of the standard PEEK cage in patients receiving minimally invasive transforaminal lumbar interbody fusion (MI-TLIF).
Patients receiving 1 level MI-TLIF between October 2015 and October 2017 were included with a minimum of 2-year follow-up. The patients were segregated into 2 groups; Ti/PEEK group and PEEK group. Each patient was propensity-matched using preoperative age, sex, and body mass index. Early fusion rate was evaluated by computed tomography at postoperative 6 months. Clinical outcomes were assessed using the visual analog scale (VAS) and Oswestry Disability Index (ODI) scores.
After matching, there were 27 patients included in each group. The demographics, diagnosis, and surgical details were not significantly different between the 2 groups. The 6-month rate was 88.9% in Ti/PEEK group. The fusion rate and cage subsidence rate had no difference between the 2 groups. The complication rate in the Ti/PEEK group was comparable to that in the PEEK group. There was no difference in VAS and ODI scores during a 2-year follow-up period.
The use of Ti/PEEK composite cage was as safe and effective as the use of PEEK cage in MI-TLIF. The 6-month fusion rate was 88.9%. Our finding revealed comparable clinical results for surgeons using Ti/PEEK composite cages in MI-TLIF compared to those using the PEEK cage.
回顾性病例对照研究。
本研究旨在比较接受微创经椎间孔腰椎椎间融合术(MI-TLIF)的患者中,钛-聚醚醚酮(Ti/PEEK)复合椎间融合器与标准PEEK椎间融合器的临床和影像学结果。
纳入2015年10月至2017年10月期间接受单节段MI-TLIF且至少随访2年的患者。将患者分为两组;Ti/PEEK组和PEEK组。根据术前年龄、性别和体重指数对每位患者进行倾向匹配。术后6个月通过计算机断层扫描评估早期融合率。使用视觉模拟量表(VAS)和奥斯威斯利功能障碍指数(ODI)评分评估临床结果。
匹配后,每组纳入27例患者。两组间的人口统计学、诊断和手术细节无显著差异。Ti/PEEK组6个月时的融合率为88.9%。两组间的融合率和椎间融合器沉降率无差异。Ti/PEEK组的并发症发生率与PEEK组相当。在2年随访期内,VAS和ODI评分无差异。
在MI-TLIF中,使用Ti/PEEK复合椎间融合器与使用PEEK椎间融合器一样安全有效。6个月时的融合率为88.9%。我们的研究结果表明,与使用PEEK椎间融合器的外科医生相比,在MI-TLIF中使用Ti/PEEK复合椎间融合器的外科医生获得了相当的临床结果。